Drug Administration Routes
"Drug Administration Routes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The various ways of administering a drug or other chemical to a site in a patient or animal from where the chemical is absorbed into the blood and delivered to the target tissue.
| Descriptor ID |
D004333
|
| MeSH Number(s) |
E02.319.267
|
| Concept/Terms |
Drug Administration Routes- Drug Administration Routes
- Administration Routes, Drug
- Administration Route, Drug
- Drug Administration Route
- Route, Drug Administration
- Routes, Drug Administration
|
Below are MeSH descriptors whose meaning is more general than "Drug Administration Routes".
Below are MeSH descriptors whose meaning is more specific than "Drug Administration Routes".
This graph shows the total number of publications written about "Drug Administration Routes" by people in this website by year, and whether "Drug Administration Routes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 2 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 2 | 2 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 1 | 1 |
| 2011 | 0 | 2 | 2 |
| 2016 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Administration Routes" by people in Profiles.
-
Gilbert LR, Tawiah NA, Adepoju OE. Exploring racial and secondary substance use differences in route of administration of opioid drugs: Analysis of the 2015-2019 treatment admission data. J Subst Use Addict Treat. 2024 Jul; 162:209365.
-
Roytman M, Ramkissoon R, Wu C, Hong L, Trujillo R, Huddleston L, Poerzgen P, Seto T, Wong L, Tsai N. Examining the clinical course of genotype 1 chronic hepatitis C patients treated with the cosmos regimen: including patients with advanced liver disease and East Asian ancestry. Hepatol Int. 2016 Jul; 10(4):616-23.
-
Arroyo-Novoa CM, Figueroa-Ramos MI, Miaskowski C, Padilla G, Paul SM, Rodr?guez-Ortiz P, Stotts NA, Puntillo KA. Efficacy of small doses of ketamine with morphine to decrease procedural pain responses during open wound care. Clin J Pain. 2011 Sep; 27(7):561-6.
-
Tulloch I, Ghazaryan N, Mexhitaj I, Ordonez D, Angulo JA. Role of neurokinin-1 and dopamine receptors on the striatal methamphetamine-induced proliferation of new cells in mice. Brain Res. 2011 Jul 05; 1399:33-9.
-
Puig-Ramos A, Santiago GS, Segarra AC. U-69593, a kappa opioid receptor agonist, decreases cocaine-induced behavioral sensitization in female rats. Behav Neurosci. 2008 Feb; 122(1):151-60.
-
Merrill GF, Merrill JH, Golfetti R, Jaques KM, Hadzimichalis NS, Baliga SS, Rork TH. Antiarrhythmic properties of acetaminophen in the dog. Exp Biol Med (Maywood). 2007 Oct; 232(9):1245-52.
-
Fort TJ, Garc?a-Crescioni K, Agricola HJ, Brezina V, Miller MW. Regulation of the crab heartbeat by crustacean cardioactive peptide (CCAP): central and peripheral actions. J Neurophysiol. 2007 May; 97(5):3407-20.
-
Todorovic C, Jahn O, Tezval H, Hippel C, Spiess J. The role of CRF receptors in anxiety and depression: implications of the novel CRF1 agonist cortagine. Neurosci Biobehav Rev. 2005; 29(8):1323-33.
-
Byers DM, Irwin LN, Moss DE, Sumaya IC, Hohmann CF. Prenatal exposure to the acetylcholinesterase inhibitor methanesulfonyl fluoride alters forebrain morphology and gene expression. Brain Res Dev Brain Res. 2005 Aug 08; 158(1-2):13-22.
-
Patravale VB, Date AA, Kulkarni RM. Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol. 2004 Jul; 56(7):827-40.